Progression in breast cancer cancers cdk6. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Mammary Glands, Human Axilla Neoplastic Stem Cells Lymph Nodes Epithelial Cells Cell Line Nipples Neoplastic Cells, Circulating

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases47

Disease Progression Breast Neoplasms Carcinoma, Ductal, Breast Neoplasm Metastasis Neoplasm Invasiveness Breast Diseases Ovarian Neoplasms Prostatic Neoplasms Lung Neoplasms Breast Neoplasms, Male Genetic Predisposition to Disease Carcinoma Neoplasms Carcinoma, Lobular Neoplasm Recurrence, Local Colonic Neoplasms Neoplasms, Hormone-Dependent Carcinoma, Intraductal, Noninfiltrating Mammary Neoplasms, Experimental Stomach Neoplasms Cell Transformation, Neoplastic Pancreatic Neoplasms Lymphatic Metastasis Bone Neoplasms Uterine Cervical Neoplasms Adenocarcinoma Fibrocystic Breast Disease Colorectal Neoplasms Carcinoma, Squamous Cell Carcinoma in Situ Urinary Bladder Neoplasms Neovascularization, Pathologic Neoplasms, Second Primary Carcinoma, Non-Small-Cell Lung Carcinoma, Ductal Endometrial Neoplasms Precancerous Conditions Disease Models, Animal Liver Neoplasms Neoplasms, Radiation-Induced Triple Negative Breast Neoplasms Neoplastic Cells, Circulating Rectal Neoplasms Inflammatory Breast Neoplasms Esophageal Neoplasms Skin Neoplasms Neoplasms, Multiple Primary

Chemicals and Drugs67

Receptors, Estrogen Receptor, erbB-2 Tamoxifen Receptors, Progesterone Tumor Markers, Biological Neoplasm Proteins Antineoplastic Agents Antineoplastic Agents, Hormonal RNA, Messenger Estrogens Estrogen Receptor alpha Cyclin-Dependent Kinases RNA, Small Interfering DNA, Neoplasm BRCA2 Protein BRCA1 Protein Tumor Suppressor Protein p53 Fluorouracil Cancer Vaccines Tumor Suppressor Proteins Estrogen Antagonists Aromatase Inhibitors Cyclin-Dependent Kinase 2 Antibodies, Monoclonal, Humanized Cyclin-Dependent Kinase 4 Cell Cycle Proteins Antibodies, Monoclonal Protein-Serine-Threonine Kinases Estradiol Receptor, Epidermal Growth Factor Paclitaxel Transcription Factors Antigens, Neoplasm Cyclophosphamide Estrogen Receptor Modulators Proto-Oncogene Proteins DNA-Binding Proteins RNA, Neoplasm Cyclin D1 Nitriles Anticarcinogenic Agents MicroRNAs Epirubicin Ki-67 Antigen Cyclin-Dependent Kinase 5 Nuclear Proteins Selective Estrogen Receptor Modulators Cyclins Prostate-Specific Antigen Cisplatin Proto-Oncogene Proteins c-akt Antineoplastic Agents, Phytogenic CDC2-CDC28 Kinases Cyclin-Dependent Kinase Inhibitor p27 Antibiotics, Antineoplastic Deoxycytidine Enzyme Inhibitors Protein Kinase Inhibitors Mucin-1 Antigens, CD24 Cyclin-Dependent Kinase Inhibitor p21 Cyclin E DNA Primers Cadherins Triazoles Receptors, Androgen Cyclin-Dependent Kinase 6

Analytical, Diagnostic and Therapeutic Techniques and Equipment68

Early Detection of Cancer Prognosis Mammography Neoplasm Staging Risk Factors Survival Analysis Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Chemotherapy, Adjuvant Gene Expression Profiling Mastectomy Reverse Transcriptase Polymerase Chain Reaction Survival Rate Disease-Free Survival Risk Prospective Studies Immunohistochemistry Retrospective Studies Mammary Neoplasms, Experimental Blotting, Western Risk Assessment Xenograft Model Antitumor Assays Treatment Outcome Odds Ratio Case-Control Studies Breast Self-Examination Neoplasm Transplantation Registries Multivariate Analysis Incidence Oligonucleotide Array Sequence Analysis Transplantation, Heterologous Sensitivity and Specificity Cohort Studies Kaplan-Meier Estimate Combined Modality Therapy Transfection Predictive Value of Tests Mastectomy, Segmental Tumor Burden Tissue Array Analysis Polymerase Chain Reaction Questionnaires Logistic Models SEER Program Reproducibility of Results Neoplasm Grading Clinical Trials as Topic Immunoenzyme Techniques Models, Biological Molecular Targeted Therapy Drug Screening Assays, Antitumor Gene Knockdown Techniques Confidence Intervals Drug Administration Schedule Radiotherapy, Adjuvant Ultrasonography, Mammary Biopsy Radiotherapy Disease Models, Animal Flow Cytometry Genetic Testing In Situ Hybridization, Fluorescence Biopsy, Needle DNA Mutational Analysis Breast Implants Lymph Node Excision Mammaplasty

Psychiatry and Psychology3

Breast Self-Examination Breast Feeding Smoking

Phenomena and Processes52

Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Cell Proliferation Drug Resistance, Neoplasm Genes, BRCA1 Cell Cycle Postmenopause Risk Mutation Apoptosis Premenopause Signal Transduction Cell Division Odds Ratio Menopause Time Factors Breast Feeding Cell Movement Genes, BRCA2 Down-Regulation Phosphorylation Sensitivity and Specificity Genotype Genes, erbB-2 Transfection DNA Methylation Promoter Regions, Genetic RNA Interference Up-Regulation Polymorphism, Genetic Cell Survival Dose-Response Relationship, Drug Germ-Line Mutation Cell Growth Processes Gene Expression Phenotype Gene Silencing Base Sequence Gene Amplification Genes, Tumor Suppressor Genes, p53 Epithelial-Mesenchymal Transition Genes, Neoplasm Alleles G1 Phase Transcription, Genetic Diet Parity Tumor Microenvironment Protein Binding S Phase Drug Synergism

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Incidence Questionnaires SEER Program Molecular Sequence Data Base Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care29

Risk Factors Survival Analysis Follow-Up Studies Survival Rate Disease-Free Survival Risk Prospective Studies Retrospective Studies Risk Assessment Age Factors Treatment Outcome Odds Ratio Case-Control Studies Registries Multivariate Analysis Incidence Sensitivity and Specificity Cohort Studies Kaplan-Meier Estimate Predictive Value of Tests Questionnaires Logistic Models SEER Program Reproducibility of Results Clinical Trials as Topic National Cancer Institute (U.S.)Confidence Intervals Genetic Testing Parity

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Breast Disease Progression Breast Neoplasms Receptors, Estrogen Carcinoma, Ductal, Breast Cell Line, Tumor Gene Expression Regulation, Neoplastic Receptor, erbB-2 Neoplasm Metastasis Neoplasm Invasiveness Early Detection of Cancer Tamoxifen Prognosis Receptors, Progesterone Breast Diseases Mammography Tumor Markers, Biological Neoplasm Proteins Antineoplastic Agents Neoplasm Staging Mice, Nude Ovarian Neoplasms Prostatic Neoplasms Antineoplastic Agents, Hormonal Risk Factors Lung Neoplasms Survival Analysis Breast Neoplasms, Male Genetic Predisposition to Disease Antineoplastic Combined Chemotherapy Protocols Cell Proliferation Follow-Up Studies Drug Resistance, Neoplasm Chemotherapy, Adjuvant Genes, BRCA1 Carcinoma Gene Expression Profiling Neoplasms Tumor Cells, Cultured Cell Cycle Mastectomy Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger Postmenopause Survival Rate Disease-Free Survival Risk Carcinoma, Lobular Prospective Studies Neoplasm Recurrence, Local Immunohistochemistry MCF-7 Cells Colonic Neoplasms Retrospective Studies Mutation Neoplasms, Hormone-Dependent Carcinoma, Intraductal, Noninfiltrating Mammary Neoplasms, Experimental Stomach Neoplasms Blotting, Western Estrogens Estrogen Receptor alpha Risk Assessment Cyclin-Dependent Kinases Apoptosis Premenopause Age Factors RNA, Small Interfering Signal Transduction Cell Division Survivors Xenograft Model Antitumor Assays Treatment Outcome DNA, Neoplasm Odds Ratio Cell Transformation, Neoplastic Case-Control Studies BRCA2 Protein Pancreatic Neoplasms Breast Self-Examination Menopause BRCA1 Protein Neoplasm Transplantation Time Factors Breast Feeding Cell Movement Genes, BRCA2 Tumor Suppressor Protein p53 Down-Regulation Registries United States Multivariate Analysis Incidence Fluorouracil Oligonucleotide Array Sequence Analysis Lymphatic Metastasis Transplantation, Heterologous Cancer Vaccines Tumor Suppressor Proteins Phosphorylation

No FAQ available that match "progression in breast cancer cancers cdk6"